Hyloris Pharmaceuticals Is A Belgium Based Specialty Biopharmaceutical Company Founded In 2012 And Listed On Euronext Brusselsthe Company Focuses On Re Engineering Existing Medications To Meet Unmet Medical Needsutilizing Regulatory Pathways Like The U S505 B2Framework To Streamline Development Processes Hyloris Aims To Improve Patient Outcomes By Reformulating Or Repurposing Drugs To Enhance Their Efficacysafetyor Deliverythe Company Operates With A Dedicated Research Facility And Collaborates With Key Opinion Leaders And Partnersits Portfolio Includes Three Marketed Products And Two High Barrier Genericswith A Core Focus On Cardiovascular Products And Value Added Medicines Through Reformulation Technologieshyloris Has A Commercial Presence In Europe And The U S Emphasizing Partnerships With Healthcare Systems To Provide Cost Effectivepatient Centric Solutions
United States
